Research on the relationship between obesity and breast cancer has been deepened in recent years.Obese breast cancer patients have poorer prognosis than normal-weight patients.Weight variation is correlated with relapse in breast cancer survivors.The role of adipokines in this process can not be ignored.The correlations between adipokines,estrogen,cell proliferation,angiogenesis and breast cancer prognosis are reviewed in this article.

Acute leukemia (AL) is an early hematopoietic stem/progenitor cell malignant cloning disease.Minimal residual disease and drug resistance are considered to be the origin of relapse and refractory.Recently,more and more evidences have shown that the interaction between leukemia cells and stromal cells or extracellular matrix in the bone marrow microenvironment can promote their survival,and enhance the resistance to conventional chemotherapy drugs.Integrin is the major molecule mediating the adhesion between leukemia cells and extracellular matrix (cellular and non cellular components),which plays a key role in cell proliferation,survival and other biological processes;however,the mechanism is not fully understood yet.This paper will review molecular mechanisms of the relationship between integrin and AL discovered recently.

To define the diagnostic thought on TCM syndrome in animal model of modern medicine disease.To diagnose "apparent syndrome" outside and "hidden syndrome" inside of TCM syndrome differentiation existed possibly in the model animal by multi-aspectual indexes such as observing the appearance of modeled animal,examining the laboratory indexes and morphology,disproving by prescription and medicine etc.It is an effective method of diagnosing TCM syndrome in animal model of modern medicine disease that using multi-aspect and multi-index diagnostic standard.

The difference and similarity between the WEIQI theory of TCM and clinical nutrition theory of modern medicine (parenteral and enteral nutrition) was discussed. The application of two theories to clinical medicine have been extensive. The purposes are identical although they have different concepts and principles as well as methods, and two theories should be more helpful and useful if used simultaneously in practice.

Objective To explore the clinical effect of combined octreotide and omeprazole for the treatment of bleeding of esophageal and gastric varices(BEV),analyze its security and provide objective basis for clinical treatment.
Methods 92 patients with BEV were randomly selected .According to the treatment methods , they were randomly divided into the control group and observation group .45 cases in the control group were treated with octreotide ,47 cases in observation group were treated with omeprazole on the basis of the control group .The main indexes were the treatment effect,48h rebleeding rate,bleeding time and volume of blood transfusion and adverse reaction .Results The total effective rate of the observation group was 93.62%,more than that of control group 82.22%,the difference was statistically significant(χ2 =6.24,P<0.05).The effective rate of the observation group was 6.38%,lower than that of the control group 17.78%,the difference was statistically significant (χ2 =6.17,P<0.05).The bleeding time of the observation group was (30.41 ±1.82) h,less than that of the control group (41.83 ±2.69) h,the difference was statistically significant (t =9.47,P <0.05).The blood transfusion of the observation group was (374.16 ± 28.30)mL,less than the control group(582.33 ±36.19)mL,the difference was statistically significant (t=12.31, P<0.05).48h the rebleeding rate of the observation group was 6.38%,lower than that of the control group 20.00%,the difference was statistically significant (χ2 =5.90,P<0.05).The adverse reactions of two groups had no significant difference(χ2 =2.78,P>0.05).Conclusion There is the better for clinical effect of combined octreoti-de and omeprazole for the treatment of BEV , which could reduce the rebleeding rate , shorten the bleeding time , decrease the volume of blood transfusion ,and there was no obvious adverse reactions .

Objective To explore clinical value of different administration modes applied to treat the asthma combined with chronic obstructive pulmonary disease ( COPD ) .Methods Clinical data of 180 patients with bronchial asthma combined with COPD admitted by the department of respiratory medicine of the Hospital from June 2013 to June 2015 were retrospectively analyzed, and such patients were divided into three groups including 58 patients in the control group, 60 patients in the observation group A and 62 patients in observation group B ( n =62 ) in random cross double-blind method.The patients in the control group were administered and treated with placebo ( once in the morning and at night daily respectively) , the patients in the observation group A were administered and treated with 2.5 μg of tiotropium bromide ( once in the morning and at night daily respectively), and the patients in the observation group B were treated with 2.5 μg of tiotropium bromide (once at night daily respectively), and the treatment efficacy on three groups of patients were observed.Results Average questionnaire scores of FEV1, AUC0 ~24 h , FEV1(0 ~24 h) peak valley value, PEFam , PEFpm , FEV1 and ACQ -7 in 24 hours of patients in the observation group A and observation group B, there were no statistically significant differences between two groups;Questionnaire scores of FEV1, AUC0 ~24 h , FEV1(0 ~24 h) peak valley value, PEFam , PEFpm , FEV1 and ACQ-7 in 24 hours of patients in the observation group A and observation group B were significantly higher than such indexes of patients in the control group, and the differences were statistically significant ( P <0.05 ) .Conclusion Two different dosage regimens of tiotropium bromide with daily dose of 5 μg can significantly keep the bronchus expanding for 24 h, and delivers significant efficacy on the asthma combined with COPD treatment.

The 15th World Conference on Lung Cancer (WCLC) received about 210 abstracts on radiotherapy.These abstracts covered many realms,including the efficacy,safety,evaluation methods and dose fractionation study of stereotactic body radiotherapy (SBRT) on early stage non-small-cell lung cancer (NSCLC); control studies of high and standard radiation dose,different chemotherapy regimens and whether combined cetuximab in concurrent radiochemotherapy on locally advanced NSCLC clinical significance of postoperative 3D-conformal radiotherapy (3D-CRT) for patients with p Ⅲ A-N2 NSCLC after complete resection; the efficacy and safety of TKIs in combination with whole brain radiation therapy (WBRT) in NSCLC patients with multiple brain metastases,as well as the influence of EGFR mutation status on the curative effect.Besides,there are many reports about radiotherapy protection,toxicity,efficacy,prognosis and life quality assessment.

Objective To explore the clinical efficacy of combined anterior and posterior operation in the treatment of cervical spondylotic myelopathy.Methods 50 patients with cervical spondylotic myelopathy,in accordance with anterior,posterior surgery and combined anterior and posterior operation three different surgical methods,were divided into the treatment group A(21 cases),group B(16 cases) and group C(13 cases).The surgical efficacy was analyzed.Results Before treatment,the JOA score among the three groups had no significant difference [Cgroup (9.3 ± 2.3) points,B group (9.4 ± 1.4) points,A group (9.2 ± 2.2) points].After treatment,the JOA score in group C (14.5 ± 3.4) points was significantly higher than that of group A (12.6 ± 1.2) points (t =3.09,P ＜0.05) and group B (11.3 ± 1.4) points (t =4.62,P ＜ 0.05).The excellent and good rate of C group was 76.9％,which was significantly higher than that in group A 43.8％ (x2 =3.84,P ＜ 0.05) and group B 42.8％ (x2 =4.11,P ＜ 0.05).Conclusion Combined anterior and posterior operation in the treatment of cervical spondylotic myelopathy has better recovery of spinal cord function,complete decompression,significant effect,less complications,etc.,it is an effective,safe and reliable treatment.

The article expatiated on the process of rabbit respiration regulation and respiratory failure designing experiment.It can fully excitate students'potential and strengthen the teaching effects.It is very important for cultivating students'synthesis diathesis and abilities.

Objective:To inhibit GR expression in macrophage RAW264.7 cells of mouse by RNAi and Cre-loxP system.Methods:Two pairs of RNAi target sequence against GR gene were designed and inserted into pBS/U6-Neo vehicle.Recombinant plasmid constructed by Cre-loxP system and RNAi was identified by PCR and sequencing.The recombinant plasmid and Cre-ERT2 plasmid was transfected into the mouse macrophage RAW264.7 cells,in which GR expression was measured on mRNA and protein level respectively by RT-PCR and Western blot.Results:GR expression on mRNA and protein level was significantly inhibited by the two recombinant plasmid against GR gene.Conclusion:Combination using of RNAi and Cre-loxP system could inhabit GR expression in mouse macrophage RAW264.7 cells.